BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29648530)

  • 1. Clinical and histological features of antineutrophil cytoplasmic antibody-associated vasculitis related to antithyroid drugs
.
    Hasegawa J; Hoshino J; Sekine A; Hayami N; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Hazue R; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y
    Clin Nephrol; 2018 Jun; 89(6):438-444. PubMed ID: 29648530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
    Balavoine AS; Glinoer D; Dubucquoi S; Wémeau JL
    Thyroid; 2015 Dec; 25(12):1273-81. PubMed ID: 26414658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease.
    Aoki Y; Kitazawa K; Kobayashi H
    Paediatr Int Child Health; 2019 May; 39(2):142-145. PubMed ID: 29457989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of agranulocytosis and anti-neutrophil cytoplasmic antibody-associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database.
    Han JY; Lee JM; Jung SY; Kim MS; Lee SW; Kronbichler A; Tizaoui K; Koyanagi A; Kim EY; Song K; Chae HW; Yon DK; Shin JI; Smith L
    Fundam Clin Pharmacol; 2024 Aug; 38(4):780-788. PubMed ID: 38342499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
    Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
    Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study.
    Andrade GC; Maia FCP; Mourão GF; Rosario PW; Calsolari MR
    Braz J Otorhinolaryngol; 2019; 85(5):636-641. PubMed ID: 30057255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.
    Prendecki M; Martin L; Tanna A; Antonelou M; Pusey CD
    J Rheumatol; 2018 May; 45(5):686-689. PubMed ID: 29545453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.
    Noh JY; Yasuda S; Sato S; Matsumoto M; Kunii Y; Noguchi Y; Mukasa K; Ito K; Ito K; Sugiyama O; Kobayashi H; Nihojima S; Okazaki M; Yokoyama S
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2806-11. PubMed ID: 19491223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study.
    Slot MC; Links TP; Stegeman CA; Tervaert JW
    Arthritis Rheum; 2005 Feb; 53(1):108-13. PubMed ID: 15696557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult pulmonary hemorrhage as a rare presentation of propylthiouracil-induced vasculitis.
    Tu YL; Tsai YC; Huang JL; Yao TC
    Pediatrics; 2011 Jan; 127(1):e245-9. PubMed ID: 21135005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.